213 related articles for article (PubMed ID: 24123308)
1. Characterization of human paraoxonase 1 variants suggest that His residues at 115 and 134 positions are not always needed for the lactonase/arylesterase activities of the enzyme.
Bajaj P; Tripathy RK; Aggarwal G; Pande AH
Protein Sci; 2013 Dec; 22(12):1799-807. PubMed ID: 24123308
[TBL] [Abstract][Full Text] [Related]
2. Interplay between amino acid residues at positions 192 and 115 in modulating hydrolytic activities of human paraoxonase 1.
Bajaj P; Aggarwal G; Tripathy RK; Pande AH
Biochimie; 2014 Oct; 105():202-10. PubMed ID: 25107406
[TBL] [Abstract][Full Text] [Related]
3. Towards Understanding the Catalytic Mechanism of Human Paraoxonase 1: Experimental and In Silico Mutagenesis Studies.
Tripathy RK; Aggarwal G; Bajaj P; Kathuria D; Bharatam PV; Pande AH
Appl Biochem Biotechnol; 2017 Aug; 182(4):1642-1662. PubMed ID: 28161867
[TBL] [Abstract][Full Text] [Related]
4. Toward Understanding the Catalytic Mechanism of Human Paraoxonase 1: Site-Specific Mutagenesis at Position 192.
Aggarwal G; Prajapati R; Tripathy RK; Bajaj P; Iyengar AR; Sangamwar AT; Pande AH
PLoS One; 2016; 11(2):e0147999. PubMed ID: 26829396
[TBL] [Abstract][Full Text] [Related]
5. Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents.
Kirby SD; Norris JR; Richard Smith J; Bahnson BJ; Cerasoli DM
Chem Biol Interact; 2013 Mar; 203(1):181-5. PubMed ID: 23159884
[TBL] [Abstract][Full Text] [Related]
6. Refolded Recombinant Human Paraoxonase 1 Variant Exhibits Prophylactic Activity Against Organophosphate Poisoning.
Bajaj P; Tripathy RK; Aggarwal G; Datusalia AK; Sharma SS; Pande AH
Appl Biochem Biotechnol; 2016 Sep; 180(1):165-76. PubMed ID: 27131877
[TBL] [Abstract][Full Text] [Related]
7. Structure/function analyses of human serum paraoxonase (HuPON1) mutants designed from a DFPase-like homology model.
Yeung DT; Josse D; Nicholson JD; Khanal A; McAndrew CW; Bahnson BJ; Lenz DE; Cerasoli DM
Biochim Biophys Acta; 2004 Oct; 1702(1):67-77. PubMed ID: 15450851
[TBL] [Abstract][Full Text] [Related]
8. Evidence that several conserved histidine residues are required for hydrolytic activity of human paraoxonase/arylesterase.
Doorn JA; Sorenson RC; Billecke SS; Hsu C; La Du BN
Chem Biol Interact; 1999 May; 119-120():235-41. PubMed ID: 10421457
[TBL] [Abstract][Full Text] [Related]
9. Lactonases with organophosphatase activity: structural and evolutionary perspectives.
Draganov DI
Chem Biol Interact; 2010 Sep; 187(1-3):370-2. PubMed ID: 20122908
[TBL] [Abstract][Full Text] [Related]
10. The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3.
Taler-Verčič A; Goličnik M; Bavec A
Molecules; 2020 Dec; 25(24):. PubMed ID: 33348669
[TBL] [Abstract][Full Text] [Related]
11. Expression and purification of biologically active recombinant human paraoxonase 1 from inclusion bodies of Escherichia coli.
Bajaj P; Tripathy RK; Aggarwal G; Pande AH
Protein Expr Purif; 2015 Nov; 115():95-101. PubMed ID: 26003526
[TBL] [Abstract][Full Text] [Related]
12. Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities.
Bryk B; BenMoyal-Segal L; Podoly E; Livnah O; Eisenkraft A; Luria S; Cohen A; Yehezkelli Y; Hourvitz A; Soreq H
J Neurochem; 2005 Mar; 92(5):1216-27. PubMed ID: 15715671
[TBL] [Abstract][Full Text] [Related]
13. Dramatic differences in organophosphorus hydrolase activity between human and chimeric recombinant mammalian paraoxonase-1 enzymes.
Otto TC; Harsch CK; Yeung DT; Magliery TJ; Cerasoli DM; Lenz DE
Biochemistry; 2009 Nov; 48(43):10416-22. PubMed ID: 19764813
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for natural lactonase and promiscuous phosphotriesterase activities.
Elias M; Dupuy J; Merone L; Mandrich L; Porzio E; Moniot S; Rochu D; Lecomte C; Rossi M; Masson P; Manco G; Chabriere E
J Mol Biol; 2008 Jun; 379(5):1017-28. PubMed ID: 18486146
[TBL] [Abstract][Full Text] [Related]
15. The histidine 115-histidine 134 dyad mediates the lactonase activity of mammalian serum paraoxonases.
Khersonsky O; Tawfik DS
J Biol Chem; 2006 Mar; 281(11):7649-56. PubMed ID: 16407305
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase 1 activities and genetic variation in childhood obesity.
Rupérez AI; López-Guarnido O; Gil F; Olza J; Gil-Campos M; Leis R; Tojo R; Cañete R; Gil A; Aguilera CM
Br J Nutr; 2013 Nov; 110(9):1639-47. PubMed ID: 23789921
[TBL] [Abstract][Full Text] [Related]
17. Lactonase activity and status of paraoxonase 1 in Chinese women with polycystic ovarian syndrome.
Zhang Y; Liu H; He J; Xu K; Bai H; Wang Y; Zhang F; Zhang J; Cheng L; Fan P
Eur J Endocrinol; 2015 Apr; 172(4):391-402. PubMed ID: 25575948
[TBL] [Abstract][Full Text] [Related]
18. Similar Active Sites and Mechanisms Do Not Lead to Cross-Promiscuity in Organophosphate Hydrolysis: Implications for Biotherapeutic Engineering.
Purg M; Elias M; Kamerlin SCL
J Am Chem Soc; 2017 Dec; 139(48):17533-17546. PubMed ID: 29113434
[TBL] [Abstract][Full Text] [Related]
19. Low protective PON1 lactonase activity in an Arab population with high rates of coronary heart disease and diabetes.
Gugliucci A; Caccavello R; Nassar H; Abu Ahmad W; Sinnreich R; Kark JD
Clin Chim Acta; 2015 May; 445():41-7. PubMed ID: 25801214
[TBL] [Abstract][Full Text] [Related]
20. Switching a newly discovered lactonase into an efficient and thermostable phosphotriesterase by simple double mutations His250Ile/Ile263Trp.
Luo XJ; Kong XD; Zhao J; Chen Q; Zhou J; Xu JH
Biotechnol Bioeng; 2014 Oct; 111(10):1920-30. PubMed ID: 24771278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
